Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 2 Patient data at admission and possible explanations of adjacent segment infection

From: Adjacent segment infection after surgical treatment of spondylodiscitis

Patient

Interval before ASI surgery (months)

ASI level(s)

Presentation (ASI)

WBC (/mm3)

ESR (mm/h)

CRP (mg/dL)

Septicaemia

Screw loosening

Change in ASK

1

5.3

L3–4

Fever

12.7

54

86.2

Yes (Escherichia coli)

No

2

19.6

L3–4, L5–S1

BP

11.7

132

93.7

No

Yes (+cage)

15°

3

11.9

L3–4

BP

 10

83

99

No

No

4

14.4

L2–3

Decubitus ulcer

7.5

57

38.2

No

Yes

28°

5

6

T11–12

BP

10.2

73

240.7

Yes (MRSA)

Yes

26°

6

8.6

T12–L1

BP

7.1

94

71.4

Yes (Pseudomonas aeruginosa MDR)

Yes

17°

7

16.8

L3–4

BP

5.1

17

3

No

No

8

12.3

L2–3

BP

9.5

61

55.4

No

No

9

61.1

T12–L1

BP

10.3

84

203

No

Yes

10

14 days

L3–4

BP

14.3

85

84.4

No

No

11

72.3

L1–L2

Weakness

2.4

81

62.7

Yes (Staphylococcus aureus)

Yes

12

86.2

L4–5

BP

5.7

97

38.9

No

No

13

27.4

T12–L1

BP

7

84

45.5

Yes (Staphylococcus aureus)

No

14

6

L1–2

BP

14.3

140

180

No

Yes

15

17.4

L1–2

Cauda equina syndrome

8.9

90

44.8

No

Yes

16

39

T11–L1

BP

6

5

1.9

No

No

17

4.5

L3–4

Wound infection

10.2

140

274.4

No

Yes

10°

18

46

L2–3

BP

5.2

37

7.7

No

No

19

25.9

T1–2

Fever

23.4

105

270.2

Yes (Staphylococcus aureus)

No

20

9.9

L2–3

BP

34

47

63.5

No

Yes

21

4.4

T2–3

Fever

5.1

140

102.3

Yes (Pseudomonas aeruginosa MDR)

Yes

22

205.6

L3–4

GIT infection

11

84

89

Yes (Escherichia coli)

Yes

15°

23

147.3

L5–S1

BP

9.8

45

6.4

No

Yes

  1. ASI adjacent segment infection, BP back pain, WBC white blood cell count, ESR erythrocyte sedimentation rate, CRP C-reactive protein, MRSA methicillin-resistant Staphylococcus aureus, MDR multi-drug resistant, GIT gastrointestinal tract, ASK adjacent segment kyphosis